Skip to main content
Fig. 7 | Parasites & Vectors

Fig. 7

From: In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum

Fig. 7

In vivo effect of DW-3-15 on hepatic granulomas in S. japonicum-infected mice. Photomicrograph of hepatic granulomas in mice of the control group (a), mice treated with DW-3-15 400 mg/kg per day (b) and mice treated with PZQ 400 mg/kg per day (c). d Significant differences compared to the control group are indicated by **P < 0.01 and ***P < 0.001. Scale-bars: a–c, 100 μm

Back to article page